Connection

Ann-Marie Broome to Humans

This is a "connection" page, showing publications Ann-Marie Broome has written about Humans.
Connection Strength

0.271
  1. Gold Nanoparticles for the Delivery of Cancer Therapeutics. Adv Cancer Res. 2018; 139:163-184.
    View in: PubMed
    Score: 0.024
  2. Preface. Adv Cancer Res. 2018; 139:xiii-xiv.
    View in: PubMed
    Score: 0.023
  3. Biotinylated Bioluminescent Probe for Long Lasting Targeted in Vivo Imaging of Xenografted Brain Tumors in Mice. ACS Chem Neurosci. 2018 01 17; 9(1):100-106.
    View in: PubMed
    Score: 0.022
  4. Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma. Curr Neuropharmacol. 2017; 15(1):104-115.
    View in: PubMed
    Score: 0.022
  5. Delivery of a drug cache to glioma cells overexpressing platelet-derived growth factor receptor using lipid nanocarriers. Nanomedicine (Lond). 2016 Mar; 11(6):581-95.
    View in: PubMed
    Score: 0.020
  6. Dual Receptor-Targeted Theranostic Nanoparticles for Localized Delivery and Activation of Photodynamic Therapy Drug in Glioblastomas. Mol Pharm. 2015 Sep 08; 12(9):3250-60.
    View in: PubMed
    Score: 0.020
  7. Optical imaging of targeted ?-galactosidase in brain tumors to detect EGFR levels. Bioconjug Chem. 2015 Apr 15; 26(4):660-8.
    View in: PubMed
    Score: 0.019
  8. Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors. Nanoscale. 2015 Feb 07; 7(5):1782-90.
    View in: PubMed
    Score: 0.019
  9. Expanding the utility of beta-galactosidase complementation: piece by piece. Mol Pharm. 2010 Feb 01; 7(1):60-74.
    View in: PubMed
    Score: 0.013
  10. Microtubule-dependent redistribution of a cytoplasmic cornified envelope precursor. J Invest Dermatol. 2004 Jan; 122(1):29-38.
    View in: PubMed
    Score: 0.009
  11. S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem. 2003 May; 51(5):675-85.
    View in: PubMed
    Score: 0.008
  12. Targeting the KRAS a4-a5 allosteric interface inhibits pancreatic cancer tumorigenesis. Small GTPases. 2022 Jan; 13(1):114-127.
    View in: PubMed
    Score: 0.007
  13. Voltage-Dependent Anion Channels Influence Cytotoxicity of ME-344, a Therapeutic Isoflavone. J Pharmacol Exp Ther. 2020 08; 374(2):308-318.
    View in: PubMed
    Score: 0.007
  14. Predominant Distribution of the RNAi Machinery at Apical Adherens Junctions in Colonic Epithelia Is Disrupted in Cancer. Int J Mol Sci. 2020 Apr 07; 21(7).
    View in: PubMed
    Score: 0.007
  15. Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo. Ann Surg Oncol. 2019 Dec; 26(13):4782-4790.
    View in: PubMed
    Score: 0.007
  16. Isoflavone ME-344 Disrupts Redox Homeostasis and Mitochondrial Function by Targeting Heme Oxygenase 1. Cancer Res. 2019 08 15; 79(16):4072-4085.
    View in: PubMed
    Score: 0.006
  17. Mutations in DCHS1 cause mitral valve prolapse. Nature. 2015 Sep 03; 525(7567):109-13.
    View in: PubMed
    Score: 0.005
  18. Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation. Pharm Res. 2014 Jun; 31(6):1407-17.
    View in: PubMed
    Score: 0.004
  19. An optical probe for noninvasive molecular imaging of orthotopic brain tumors overexpressing epidermal growth factor receptor. Mol Cancer Ther. 2012 Oct; 11(10):2202-11.
    View in: PubMed
    Score: 0.004
  20. Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery? Small. 2011 Aug 22; 7(16):2301-6.
    View in: PubMed
    Score: 0.004
  21. Novel in vitro model for assessing susceptibility of synthetic hernia repair meshes to Staphylococcus aureus infection using green fluorescent protein-labeled bacteria and modern imaging techniques. Surg Infect (Larchmt). 2010 Oct; 11(5):449-54.
    View in: PubMed
    Score: 0.004
  22. Transglutaminase function in epidermis. J Invest Dermatol. 2005 Mar; 124(3):481-92.
    View in: PubMed
    Score: 0.002
  23. Transglutaminases in epidermis. Prog Exp Tumor Res. 2005; 38:115-24.
    View in: PubMed
    Score: 0.002
  24. Protein kinase Cdelta regulates keratinocyte death and survival by regulating activity and subcellular localization of a p38delta-extracellular signal-regulated kinase 1/2 complex. Mol Cell Biol. 2004 Sep; 24(18):8167-83.
    View in: PubMed
    Score: 0.002
  25. S100 proteins in the epidermis. J Invest Dermatol. 2004 Jul; 123(1):23-33.
    View in: PubMed
    Score: 0.002
  26. A novel tumor suppressor protein promotes keratinocyte terminal differentiation via activation of type I transglutaminase. J Biol Chem. 2003 Nov 28; 278(48):48066-73.
    View in: PubMed
    Score: 0.002
  27. S100A7 (psoriasin) interacts with epidermal fatty acid binding protein and localizes in focal adhesion-like structures in cultured keratinocytes. J Invest Dermatol. 2003 Jul; 121(1):132-41.
    View in: PubMed
    Score: 0.002
  28. A regulatory role for p38 delta MAPK in keratinocyte differentiation. Evidence for p38 delta-ERK1/2 complex formation. J Biol Chem. 2003 Sep 05; 278(36):34277-85.
    View in: PubMed
    Score: 0.002
  29. Retinoic acid and calcitriol inhibition of growth and NADH oxidase of normal and immortalized human keratinocytes. Biochim Biophys Acta. 1992 Apr 07; 1134(3):217-22.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.